CDTX
Price
$49.45
Change
+$0.12 (+0.24%)
Updated
Jun 27 closing price
Capitalization
1.04B
SNGX
Price
$1.36
Change
-$0.01 (-0.73%)
Updated
Jun 27 closing price
Capitalization
4.34M
Interact to see
Advertisement

CDTX vs SNGX

Header iconCDTX vs SNGX Comparison
Open Charts CDTX vs SNGXBanner chart's image
Cidara Therapeutics
Price$49.45
Change+$0.12 (+0.24%)
Volume$3.75M
Capitalization1.04B
Soligenix
Price$1.36
Change-$0.01 (-0.73%)
Volume$367.67K
Capitalization4.34M
CDTX vs SNGX Comparison Chart in %
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. SNGX commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Buy and SNGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (CDTX: $49.45 vs. SNGX: $1.36)
Brand notoriety: CDTX and SNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 701% vs. SNGX: 477%
Market capitalization -- CDTX: $1.04B vs. SNGX: $4.34M
CDTX [@Biotechnology] is valued at $1.04B. SNGX’s [@Biotechnology] market capitalization is $4.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileSNGX’s FA Score has 1 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • SNGX’s FA Score: 1 green, 4 red.
According to our system of comparison, both CDTX and SNGX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 4 TA indicator(s) are bullish while SNGX’s TA Score has 4 bullish TA indicator(s).

  • CDTX’s TA Score: 4 bullish, 4 bearish.
  • SNGX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CDTX and SNGX are a good buy in the short-term.

Price Growth

CDTX (@Biotechnology) experienced а +135.25% price change this week, while SNGX (@Biotechnology) price change was -20.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($1.04B) has a higher market cap than SNGX($4.34M). CDTX YTD gains are higher at: 83.966 vs. SNGX (-49.536). SNGX has higher annual earnings (EBITDA): -10.78M vs. CDTX (-192.6M). CDTX has more cash in the bank: 168M vs. SNGX (7.3M). SNGX has less debt than CDTX: SNGX (79.1K) vs CDTX (2.67M). CDTX has higher revenues than SNGX: CDTX (302K) vs SNGX (-117.03K).
CDTXSNGXCDTX / SNGX
Capitalization1.04B4.34M23,837%
EBITDA-192.6M-10.78M1,787%
Gain YTD83.966-49.536-170%
P/E RatioN/AN/A-
Revenue302K-117.03K-258%
Total Cash168M7.3M2,302%
Total Debt2.67M79.1K3,379%
FUNDAMENTALS RATINGS
CDTX vs SNGX: Fundamental Ratings
CDTX
SNGX
OUTLOOK RATING
1..100
9850
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3494
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNGX's Valuation (22) in the Biotechnology industry is somewhat better than the same rating for CDTX (86). This means that SNGX’s stock grew somewhat faster than CDTX’s over the last 12 months.

SNGX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CDTX (100). This means that SNGX’s stock grew similarly to CDTX’s over the last 12 months.

SNGX's SMR Rating (100) in the Biotechnology industry is in the same range as CDTX (100). This means that SNGX’s stock grew similarly to CDTX’s over the last 12 months.

CDTX's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for SNGX (94). This means that CDTX’s stock grew somewhat faster than SNGX’s over the last 12 months.

CDTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as SNGX (100). This means that CDTX’s stock grew similarly to SNGX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTXSNGX
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VHGEX39.450.33
+0.84%
Vanguard Global Equity Inv
GSTTX14.120.08
+0.57%
Goldman Sachs Strategic Growth Inv
EQNUX22.380.09
+0.40%
MFS Equity Income R4
WASYX23.310.09
+0.39%
Macquarie Asset Strategy Fund Cl Y
ARDGX27.380.06
+0.21%
Archer Dividend Growth

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with WINT. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
+0.24%
WINT - CDTX
94%
Closely correlated
+21.49%
NBY - CDTX
93%
Closely correlated
+0.97%
NCNA - CDTX
93%
Closely correlated
N/A
SNPX - CDTX
93%
Closely correlated
+23.37%
BPTSY - CDTX
92%
Closely correlated
N/A
More

SNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNGX has been closely correlated with ALLR. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNGX jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNGX
1D Price
Change %
SNGX100%
-0.73%
ALLR - SNGX
85%
Closely correlated
+2.12%
WINT - SNGX
82%
Closely correlated
+21.49%
RNAC - SNGX
81%
Closely correlated
-6.81%
NRXP - SNGX
81%
Closely correlated
-2.29%
CDTX - SNGX
81%
Closely correlated
+0.24%
More